Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-005176
Filing Date
2018-02-01
Accepted
2018-02-01 16:30:27
Documents
2
Period of Report
2018-02-01

Document Format Files

Seq Description Document Type Size
1 6-K tv484481_6k.htm 6-K 12638
2 EXHIBIT 10.1 tv484481_ex10-1.htm EX-10.1 47861
  Complete submission text file 0001144204-18-005176.txt   61697
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 18567224
SIC: 2834 Pharmaceutical Preparations